Division of Endocrinology and Metabolism, Department of Internal Medicine, E-Da Hospital, Kaohsiung, 82445 Taiwan.
School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, 82445 Taiwan.
Int J Med Sci. 2021 Mar 11;18(9):2076-2085. doi: 10.7150/ijms.54508. eCollection 2021.
Higher concentrations of plasma fatty acid-binding protein 3 (FABP3) play a role in the development of cardiovascular events, cerebrovascular deaths, and acute heart failure. However, little is known about the relationship between plasma FABP3 level and prolonged QT interval and reduced ejection fraction (EF). This study aimed to investigate the relationship between plasma FABP3 level and prolonged corrected QT (QTc) interval and reduced EF in patients with stable angina. Inflammatory cytokine and adipocytokine levels were also measured to investigate their associations with plasma FABP3. We evaluated 249 consecutive patients with stable angina. Circulating levels of FABP3 were measured by ELISA. In addition, 12-lead ECG and echocardiography recordings were obtained from each patient. Multiple regression analysis showed that high-density lipoprotein cholesterol, high sensitivity C-reactive protein (hs-CRP), white blood cell (WBC) count, visfatin, adiponectin, FABP4, heart rate, QTc interval, left atrial diameter, left ventricular mass index, end-systolic volume, end-systolic volume index, fractional shortening, and EF were independently associated with FABP3 (all <0.05). Patients with an abnormal QTc interval had a higher median plasma FABP3 level than those with a borderline and normal QTc interval. With increasing FABP3 tertiles, the patients had higher frequencies of abnormal QTc interval, left ventricular systolic dysfunction, and all-cause mortality, incrementally lower EF, higher WBC count, and higher levels of hs-CRP, visfatin, adiponectin, and FABP4. This study indicates that plasma FABP3 may act as a surrogate parameter of prolonged QTc interval and reduced EF in patients with stable angina, partially through the effects of inflammation or cardiomyocyte injury. Further studies are required to elucidate whether plasma FABP3 plays a role in the pathogenesis of QTc prolongation and reduced EF.
血浆脂肪酸结合蛋白 3(FABP3)浓度升高与心血管事件、脑血管死亡和急性心力衰竭的发生有关。然而,血浆 FABP3 水平与 QT 间期延长和射血分数(EF)降低之间的关系知之甚少。本研究旨在探讨稳定型心绞痛患者血浆 FABP3 水平与 QT 间期延长和 EF 降低之间的关系。还测量了炎症细胞因子和脂肪细胞因子的水平,以研究它们与血浆 FABP3 的关系。
我们评估了 249 例连续的稳定型心绞痛患者。通过 ELISA 测量循环 FABP3 水平。此外,从每位患者获得 12 导联心电图和超声心动图记录。多元回归分析显示,高密度脂蛋白胆固醇、高敏 C 反应蛋白(hs-CRP)、白细胞(WBC)计数、内脂素、脂联素、FABP4、心率、QTc 间期、左心房直径、左心室质量指数、收缩末期容积、收缩末期容积指数、射血分数与 FABP3 独立相关(均<0.05)。QTc 间期异常患者的血浆 FABP3 中位数水平高于 QTc 间期临界值和正常患者。随着 FABP3 三分位值的升高,QTc 间期异常、左心室收缩功能障碍和全因死亡率的患者比例逐渐增加,EF 值逐渐降低,WBC 计数逐渐升高,hs-CRP、内脂素、脂联素和 FABP4 水平逐渐升高。
本研究表明,在稳定型心绞痛患者中,血浆 FABP3 可能是 QT 间期延长和 EF 降低的替代参数,部分通过炎症或心肌细胞损伤的作用。需要进一步研究以阐明血浆 FABP3 是否在 QT 间期延长和 EF 降低的发病机制中发挥作用。